We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Dr. Reddy’s Files First Paragraph IV ANDA Against Teva’s 40mg Copaxone
Dr. Reddy’s Files First Paragraph IV ANDA Against Teva’s 40mg Copaxone
Indian generics firm Dr. Reddy’s has filed the first patent challenge against Teva’s blockbuster multiple sclerosis drug Copaxone’s 40 mg, introducing a new chapter to the Israeli drugmaker’s efforts to protect its multibillion dollar product.